Position in DHR
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$313,720
+$1,449 QoQ
Shares Held
1,647
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#1,573
of 2,098 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DHR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Grey Fox Wealth Advisors, LLC holds $564,901 across 2 Diagnostics & Research names. DHR ranks #1 (55.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
This page
|
1,647 | $313,720 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
501 | $251,181 |
All Filings in DHR
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $313,720 | 1,647 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $312,271 | 1,647 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $377,031 | 1,647 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $334,662 | 1,688 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $369,004 | 1,868 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $406,720 | 1,984 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $449,229 | 1,957 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $544,085 | 1,957 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $475,964 | 1,905 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $491,948 | 1,970 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $473,090 | 2,045 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $515,303 | 2,077 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $537,360 | 2,239 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $614,473 | 2,438 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $644,705 | 2,429 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||